Patents by Inventor D. Stave Kohtz

D. Stave Kohtz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR IDENTIFYING SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20090136990
    Abstract: The present invention relates to a method for diagnosing Alzheimer's disease and Parkinson's disease in a subject by analyzing the expression of Semaphorin 3 and downstream effectors. It also provides a method for identifying a substance useful in the prevention or treatment of Alzheimer's disease and Parkinson's disease, and a method of using such substance in the treatment of Alzheimer's disease and Parkinson's disease.
    Type: Application
    Filed: January 13, 2009
    Publication date: May 28, 2009
    Applicant: Mount Sinai School of Medicine of New York University
    Inventors: Paul F. Good, D. Stave Kohtz
  • Methods for diagnosing and treating alzheimer's disease and parkinson's disease
    Publication number: 20030032070
    Abstract: The present invention relates to a method for diagnosing Alzheimer's disease and Parkinson's disease in a subject by analyzing the expression of Semaphorin 3 and downstream effectors. It also provides a method for identifying a substance useful in the prevention or treatment of Alzheimer's disease and Parkinson's disease, and a method of using such substance in the treatment of Alzheimer's disease and Parkinson's disease.
    Type: Application
    Filed: July 19, 2002
    Publication date: February 13, 2003
    Applicant: Mt. Sinai School of Medicine
    Inventors: Paul F. Good, D. Stave Kohtz
  • Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor
    Patent number: 5807999
    Abstract: The present invention relates to: 1) A monoclonal antibody (mAb) that binds selectively to phosphorylated histone H1 and not to nonphosphorylated histone H1 and its use. In one embodiment, the mAb of the present invention binds selectively to histone H1 phosphorylated at the 12D11 epitope as defined herein, and 2) A cell producing a monoclonal antibody which binds selectively to phosphorylated histone H1 and has been shown to distinguish between histone H1 phosphorylated at the 12D11 epitope and histone H1 nonphosphorylated at this epitope.
    Type: Grant
    Filed: February 1, 1993
    Date of Patent: September 15, 1998
    Assignee: Mt. Sinai School of Medicine of the City University of New York
    Inventor: D. Stave Kohtz